Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Personalized Brain Stimulation to Aid Stroke Recovery

Tests personalized brain stimulation with occupational therapy in adults with stroke.

Plain-language title generated from the registry record
Registry title: Personalized Transcranial Direct Current Stimulation in Stroke Recovery

Key facts

Where
Houston, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06286800, who can take part

Where in United States

  • Houston Methodist HospitalHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The Methodist Hospital Research Institute
Trial code
NCT06286800
Record updated
21 September 2026
Original description
The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.Read full original descriptionShow less

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.

Inclusion: Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging resulting in hemiparesis (MRC 1-4); Age more than 18, Male or Female, All racial and ethnic groups; Entry into the study >3 months post onset; Modified Ashworth Scale Score <3 in the involved upper extremity; Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand; Able to follow 2 step commands.

Exclusion: Patients with metallic implants in the head, patients with pacemakers, patients with craniotomies, including burr holes who cannot be safely stimulated; Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as unable to follow study instructions); Patients with unstable cardiac arrhythmia; Patients with seizures; Patients with severe uncontrolled medical problems (e.g. cardiovascular disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age,epilepsy or others); Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.); Pregnancy; Non-English speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services.

ClinicalTrials.gov NCT06286800